Cargando…
A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering
CRISPR/Cas9-based technologies are revolutionising the way we engineer microbial cells. One of the key advantages of CRISPR in strain design is that it enables chromosomal integration of marker-free DNA, eliminating laborious and often inefficient marker recovery procedures. Despite the benefits, as...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104256/ https://www.ncbi.nlm.nih.gov/pubmed/37066237 http://dx.doi.org/10.21203/rs.3.rs-2738543/v1 |
_version_ | 1785026000717873152 |
---|---|
author | Yuzbashev, Tigran Yuzbasheva, Evgeniya Melkina, Olga Patel, Davina Bubnov, Dmitrii Dietz, Heiko Ledesma-Amaro, Rodrigo |
author_facet | Yuzbashev, Tigran Yuzbasheva, Evgeniya Melkina, Olga Patel, Davina Bubnov, Dmitrii Dietz, Heiko Ledesma-Amaro, Rodrigo |
author_sort | Yuzbashev, Tigran |
collection | PubMed |
description | CRISPR/Cas9-based technologies are revolutionising the way we engineer microbial cells. One of the key advantages of CRISPR in strain design is that it enables chromosomal integration of marker-free DNA, eliminating laborious and often inefficient marker recovery procedures. Despite the benefits, assembling CRISPR/Cas9 editing systems is still not a straightforward process, which may prevent its use and applications. In this work, we have identified some of the main limitations of current Cas9 toolkits and designed improvements with the goal of making CRISPR technologies easier to access and implement. These include 1) A system to quickly switch between marker-free and marker-based integration constructs using both a Cre-expressing and standard Escherichia coli strains, 2) the ability to redirect multigene integration cassettes into alternative genomic loci via Golden Gate-based exchange of homology arms, 3) a rapid, simple in-vivo method to assembly guide RNA sequences via recombineering between Cas9-helper plasmids and single oligonucleotides. We combine these methodologies with well-established technologies into a comprehensive toolkit for efficient metabolic engineering using CRISPR/Cas9. As a proof of concept, we generated and characterized a library of 137 promoters and built a de novo Yarrowia lipolytica strain synthetizing 373.8 mg/L homogentisic acid. |
format | Online Article Text |
id | pubmed-10104256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-101042562023-04-15 A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering Yuzbashev, Tigran Yuzbasheva, Evgeniya Melkina, Olga Patel, Davina Bubnov, Dmitrii Dietz, Heiko Ledesma-Amaro, Rodrigo Res Sq Article CRISPR/Cas9-based technologies are revolutionising the way we engineer microbial cells. One of the key advantages of CRISPR in strain design is that it enables chromosomal integration of marker-free DNA, eliminating laborious and often inefficient marker recovery procedures. Despite the benefits, assembling CRISPR/Cas9 editing systems is still not a straightforward process, which may prevent its use and applications. In this work, we have identified some of the main limitations of current Cas9 toolkits and designed improvements with the goal of making CRISPR technologies easier to access and implement. These include 1) A system to quickly switch between marker-free and marker-based integration constructs using both a Cre-expressing and standard Escherichia coli strains, 2) the ability to redirect multigene integration cassettes into alternative genomic loci via Golden Gate-based exchange of homology arms, 3) a rapid, simple in-vivo method to assembly guide RNA sequences via recombineering between Cas9-helper plasmids and single oligonucleotides. We combine these methodologies with well-established technologies into a comprehensive toolkit for efficient metabolic engineering using CRISPR/Cas9. As a proof of concept, we generated and characterized a library of 137 promoters and built a de novo Yarrowia lipolytica strain synthetizing 373.8 mg/L homogentisic acid. American Journal Experts 2023-04-04 /pmc/articles/PMC10104256/ /pubmed/37066237 http://dx.doi.org/10.21203/rs.3.rs-2738543/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Article Yuzbashev, Tigran Yuzbasheva, Evgeniya Melkina, Olga Patel, Davina Bubnov, Dmitrii Dietz, Heiko Ledesma-Amaro, Rodrigo A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering |
title | A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering |
title_full | A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering |
title_fullStr | A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering |
title_full_unstemmed | A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering |
title_short | A DNA assembly toolkit to unlock the CRISPR/Cas9 potential for metabolic engineering |
title_sort | dna assembly toolkit to unlock the crispr/cas9 potential for metabolic engineering |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104256/ https://www.ncbi.nlm.nih.gov/pubmed/37066237 http://dx.doi.org/10.21203/rs.3.rs-2738543/v1 |
work_keys_str_mv | AT yuzbashevtigran adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT yuzbashevaevgeniya adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT melkinaolga adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT pateldavina adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT bubnovdmitrii adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT dietzheiko adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT ledesmaamarorodrigo adnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT yuzbashevtigran dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT yuzbashevaevgeniya dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT melkinaolga dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT pateldavina dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT bubnovdmitrii dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT dietzheiko dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering AT ledesmaamarorodrigo dnaassemblytoolkittounlockthecrisprcas9potentialformetabolicengineering |